The Journal of Bone and Joint Surgery (American). 2006;88:953-958.
doi:10.2106/JBJS.E.00120
© 2006 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the exam for this article:
Adult Hip Reconstruction Test 20: Summer 2006 (publication date August 15, ...
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Related articles in JBJS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maury, A. C.
Right arrow Articles by Gross, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maury, A. C.
Right arrow Articles by Gross, A.
Related Collections
Right arrow Adult Hip
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

Proximal Femoral Allograft Treatment of Vancouver Type-B3 Periprosthetic Femoral Fractures After Total Hip Arthroplasty

Anthony C. Maury, MSc, FRCS(T&O)1, Ari Pressman, MD, FRCSC1, Barry Cayen, MD1, Paul Zalzal, MD, FRCSC1, David Backstein, MD, FRCSC1 and Allan Gross, MD, FRCSC1

1 Mount Sinai Hospital, 600 University Avenue, Suite 476A, Toronto, ON M5G 1X5, Canada. E-mail address for A.C. Maury: acjamaury{at}doctors.org

Investigation performed at Mount Sinai Hospital, Toronto, Ontario, Canada

NOTE: A.C. Maury would like to acknowledge the generous sponsorship of his clinical fellowship at Mount Sinai Hospital, Toronto, Ontario, Canada, by the John Charnley Trust, which facilitated completion of this study.

In support of their research for or preparation of this manuscript, one or more of the authors received grants or outside funding from the John Charnley Trust. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.


Background: Periprosthetic femoral fractures following total hip arthroplasty are becoming more prevalent. When a fracture occurs in a femur with substantial proximal bone deficiency, the surgical options for revision are limited. One option includes the use of a proximal femoral allograft.

Methods: We retrospectively assessed the results and complications of the use of a proximal femoral allograft to treat twenty-five Vancouver type-B3 periprosthetic fractures in twenty-four patients. The mean duration of follow-up was 5.1 years. Clinical results were graded with use of the Harris hip score. Radiographs were assessed for evidence of trochanteric union, host-allograft union, allograft resorption, and component loosening or fracture. Failure of the procedure was defined as the need for revision surgery requiring graft removal.

Results: The mean postoperative Harris hip score was 70.8. At the time of the final follow-up, twenty-one of the twenty-four patients reported no or mild pain and twenty-three patients were able to walk; fifteen required a walking aid. The greater trochanter united in seventeen of the twenty-five hips, and osseous union of the allograft to the host femur occurred in twenty hips. There was mild graft resorption in four hips and moderate graft resorption in two. Four (16%) of the twenty-five hips required repeat revision.

Conclusions: The use of a proximal femoral allograft for the treatment of a Vancouver type-B3 periprosthetic femoral fracture can provide a satisfactory result in terms of pain relief and function at five years.

Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?

Related articles in JBJS:

Proximal Femoral Allograft Treatment of Vancouver Type-B3 Periprosthetic Femoral Fractures After Total Hip Arthroplasty. Surgical Technique
Catherine F. Kellett, Petros J. Boscainos, Anthony C. Maury, Ari Pressman, Barry Cayen, Paul Zalzal, David Backstein, and Allan Gross
JBJS 2007 89: 68-79. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
JBJSHome page
T. Bhattacharyya, D. Chang, J. B. Meigs, D. M. Estok II, and H. Malchau
Mortality After Periprosthetic Fracture of the Femur
J. Bone Joint Surg. Am., December 1, 2007; 89(12): 2658 - 2662.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
C. F. Kellett, P. J. Boscainos, A. C. Maury, A. Pressman, B. Cayen, P. Zalzal, D. Backstein, and A. Gross
Proximal Femoral Allograft Treatment of Vancouver Type-B3 Periprosthetic Femoral Fractures After Total Hip Arthroplasty. Surgical Technique
J. Bone Joint Surg. Am., March 1, 2007; 89(2_suppl_1): 68 - 79.
[Abstract] [Full Text] [PDF]